IL148116A0 - Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 - Google Patents

Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11

Info

Publication number
IL148116A0
IL148116A0 IL14811600A IL14811600A IL148116A0 IL 148116 A0 IL148116 A0 IL 148116A0 IL 14811600 A IL14811600 A IL 14811600A IL 14811600 A IL14811600 A IL 14811600A IL 148116 A0 IL148116 A0 IL 148116A0
Authority
IL
Israel
Prior art keywords
alkyl
alkynyl
alkenyl
alpha
hydrocarbon substituent
Prior art date
Application number
IL14811600A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL148116A0 publication Critical patent/IL148116A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14811600A 1999-09-06 2000-08-28 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 IL148116A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202900 1999-09-06
PCT/EP2000/008406 WO2001018027A1 (en) 1999-09-06 2000-08-28 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11

Publications (1)

Publication Number Publication Date
IL148116A0 true IL148116A0 (en) 2002-09-12

Family

ID=8240610

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14811600A IL148116A0 (en) 1999-09-06 2000-08-28 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
IL148116A IL148116A (en) 1999-09-06 2002-02-12 Non-aromatic estrogenic steroids with position 11 hydrocarbon converters

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL148116A IL148116A (en) 1999-09-06 2002-02-12 Non-aromatic estrogenic steroids with position 11 hydrocarbon converters

Country Status (24)

Country Link
US (1) US6677329B1 (xx)
EP (1) EP1224204B1 (xx)
JP (1) JP2003508541A (xx)
KR (1) KR20020092907A (xx)
CN (2) CN100354299C (xx)
AT (1) ATE295851T1 (xx)
AU (1) AU770331B2 (xx)
BR (1) BR0013769A (xx)
CA (1) CA2382489C (xx)
CZ (1) CZ2002831A3 (xx)
DE (1) DE60020260T2 (xx)
EC (1) ECSP013947A (xx)
ES (1) ES2241657T3 (xx)
HU (1) HUP0202595A3 (xx)
IL (2) IL148116A0 (xx)
MX (1) MXPA02001831A (xx)
NO (1) NO20021079L (xx)
NZ (1) NZ517281A (xx)
PL (1) PL353826A1 (xx)
RU (1) RU2245886C2 (xx)
SK (1) SK3282002A3 (xx)
TR (1) TR200200575T2 (xx)
WO (1) WO2001018027A1 (xx)
ZA (1) ZA200201250B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5209600A (en) * 1999-04-06 2000-10-23 Akzo Nobel N.V. Orally active androgens
PL353826A1 (en) * 1999-09-06 2003-12-01 Akzo Nobel N.V.Akzo Nobel N.V. Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
WO2001098322A1 (en) * 2000-06-22 2001-12-27 Northeastern University Novel steroidal antiestrogens and antiandrogens and uses thereof
US8173628B2 (en) * 2000-06-22 2012-05-08 Northeastern University Steroidal antiestrogens and antiandrogens and uses thereof
JP2004505093A (ja) * 2000-07-28 2004-02-19 アクゾ・ノベル・エヌ・ベー １６α−メチルまたはエチル置換エストロゲン
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP3865501A1 (en) * 2016-03-03 2021-08-18 Crystal Pharma, S.A.U. New intermediates for the preparation of 11-methylene steroids
CN114249789B (zh) * 2020-09-23 2023-06-02 湖南普尔生物医药有限公司 一种7α-甲基-3,3-二甲氧基-5(10)-雄烯-17-酮的制备方法
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法
CN114230627B (zh) * 2021-12-31 2023-09-15 湖南新合新生物医药有限公司 一种倍他米松环氧水解物中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092645A (en) 1961-12-28 1963-06-04 Searle & Co Esters of 17alpha-alkynylester-5(10)-ene-3beta, 17beta-diols
GB1110792A (en) 1964-04-07 1968-04-24 Res Inst Medicine Chem Novel 5(10)-dehydro-steroids
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US3377366A (en) 1966-12-02 1968-04-09 Searle & Co 17alpha-alkynyl/alkenyl-11, 13beta-dialkylgon-5(10)-en-3-ones and esters thereof
US3652606A (en) 1970-08-07 1972-03-28 Searle & Co 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
CA2116829C (en) * 1993-03-05 2004-09-14 Godefridus Hermanus Johanna Deckers Use of a pregnane derivative
KR20010041698A (ko) 1998-03-09 2001-05-25 악조 노벨 엔.브이. 신규 피임 키트
PL353826A1 (en) * 1999-09-06 2003-12-01 Akzo Nobel N.V.Akzo Nobel N.V. Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11

Also Published As

Publication number Publication date
CN1185249C (zh) 2005-01-19
SK3282002A3 (en) 2002-06-04
PL353826A1 (en) 2003-12-01
ATE295851T1 (de) 2005-06-15
ECSP013947A (es) 2002-09-27
CN1637016A (zh) 2005-07-13
JP2003508541A (ja) 2003-03-04
ES2241657T3 (es) 2005-11-01
IL148116A (en) 2006-10-31
CZ2002831A3 (cs) 2002-05-15
TR200200575T2 (tr) 2002-06-21
CA2382489C (en) 2008-03-11
HUP0202595A3 (en) 2004-06-28
EP1224204B1 (en) 2005-05-18
DE60020260D1 (de) 2005-06-23
NO20021079D0 (no) 2002-03-05
NZ517281A (en) 2003-09-26
DE60020260T2 (de) 2006-01-19
AU770331B2 (en) 2004-02-19
WO2001018027A1 (en) 2001-03-15
AU7511700A (en) 2001-04-10
CN100354299C (zh) 2007-12-12
EP1224204A1 (en) 2002-07-24
HUP0202595A2 (hu) 2002-12-28
US6677329B1 (en) 2004-01-13
MXPA02001831A (es) 2002-10-23
KR20020092907A (ko) 2002-12-12
ZA200201250B (en) 2003-07-30
RU2245886C2 (ru) 2005-02-10
CN1372565A (zh) 2002-10-02
NO20021079L (no) 2002-04-29
BR0013769A (pt) 2002-04-30
CA2382489A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
ZA200201250B (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11.
DK0633893T3 (da) 17-Substituerede steroider, der er nyttige ved cancerbehandling
DK1272504T3 (da) 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener
AU665430B2 (en) 17-spiromethylene steroids
EP1310509A3 (en) Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
RS20070075A (xx) 15beta-supstituisani steroidi sa selektivnom estrogenskom aktivnošću
KR930017917A (ko) 스테로이드 유도체
EP0367576A3 (en) Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
AU2112995A (en) Use of estrone derivatives as steroid sulphatase inhibitors
NZ512923A (en) Potent sulfatase inhibitors that are metabolically stable, selective and devoid of estrogenic activity
KR950031081A (ko) 마약 또는 마약 혼합물 및 그들을 함유한 조성물의 작용을 자연스럽게 또는 급격히 중단함으로써 나타나는 증상과 관련된 증후군의 예방 또는 치료용 의약의 제조에 사용되는 항글루코코티코이드 활성을 갖는 화합물의 용도
NZ511705A (en) Methods and rapid immunoassay device for detecting progesterone and other steroids
RU2002108723A (ru) Неароматические эстрогенные стероиды с углеводородным заместителем в положении 11
ZA805249B (en) New amino-14 steriod derivatives and process for preparataion of the same
DK0559706T3 (da) 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer.
CA2260584A1 (en) Androsterone derivatives for inhibiting dna binding of ap-1 and airway smooth muscle proliferation
HK1044542A1 (en) 11-Beta-aryl-17, 17-spirothiolane-substituted steroids.
TW333536B (en) 14-17-C2-bridged steroids
MXPA03005224A (es) Esteroides de metileno como androgenos novedosos.
CO5251432A1 (es) Derivados de 3-metileno esteroides
CO5261633A1 (es) Compuestos estrogenicos

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed